anti-Coagulation Factor V (F5) Antikörper

F5 encodes an essential cofactor of the blood coagulation cascade. Zusätzlich bieten wir Ihnen Coagulation Factor V Kits (47) und Coagulation Factor V Proteine (23) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
F5 14067 O88783
F5 2153 P12259
F5 304929  
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Coagulation Factor V Antikörper auf antikoerper-online.de

Showing 10 out of 120 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Kaninchen Unkonjugiert IF (p), IHC (p) Formalin-fixed and paraffin embedded rat heart labeled with Anti-factor V Polyclonal Antibody, Unconjugated (ABIN736776) at 1:200 followed by conjugation to the secondary antibody and DAB staining. Formalin-fixed and paraffin embedded rat heart labeled with Anti-factor V Polyclonal Antibody, Unconjugated  at 1:200 followed by conjugation to the secondary antibody and DAB staining. 100 μL Anmelden zum Anzeigen 9 bis 12 Tage
304,36 €
Details
Human Kaninchen Unkonjugiert IHC, IHC (p) Immunohistochemistry: Factor V Antibody [NBP1-88114] - Staining of human cerebellum shows strong cytoplasmic positivity in purkinje cells. Immunohistochemistry-Paraffin: Factor V Antibody  - Staining of human cerebellum shows strong cytoplasmic positivity in purkinje cells. 0.1 mL Anmelden zum Anzeigen 2 bis 4 Tage
335,00 €
Details
Human Kaninchen Unkonjugiert WB   200 μL Anmelden zum Anzeigen 11 bis 13 Tage
464,29 €
Details
Human Kaninchen Cy3 IF (p)   100 μL Anmelden zum Anzeigen 18 bis 22 Tage
414,64 €
Details
Human Kaninchen Cy5 IF (p)   100 μL Anmelden zum Anzeigen 18 bis 22 Tage
414,64 €
Details
Human Kaninchen Cy5.5 IF (p)   100 μL Anmelden zum Anzeigen 18 bis 22 Tage
414,64 €
Details
Human Kaninchen Cy7 IF (p)   100 μL Anmelden zum Anzeigen 18 bis 22 Tage
414,64 €
Details
Human Kaninchen HRP IHC (p)   100 μL Anmelden zum Anzeigen 18 bis 22 Tage
414,64 €
Details
Human Kaninchen FITC IF (p)   100 μL Anmelden zum Anzeigen 18 bis 22 Tage
414,64 €
Details
Human Kaninchen Alexa Fluor 488 IF (p)   100 μL Anmelden zum Anzeigen 18 bis 22 Tage
414,64 €
Details

F5 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Mouse (Murine) , ,
,

, , , , , , , , , , , , ,
Human , , , ,
, , ,
,
, , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , ,

Weitere Antikörper gegen Coagulation Factor V Interaktionspartner

Mouse (Murine) Coagulation Factor V (F5) Interaktionspartner

  1. Platelet-derived FV contributes to the control of angiogenesis and is likely associated with thrombin (zeige F2 Antikörper) generation in hind limb ischemia model.

  2. These findings reveal a novel biological function and mechanism of the protein C (zeige PROC Antikörper) pathway in which protein S and the aPC (zeige APC Antikörper)-cleaved form of fV are cofactors for anti-inflammatory cell signaling by aPC (zeige APC Antikörper) in the context of endotoxemia and infection

  3. Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of alpha1-antitrypsin.

  4. The FVL mutation does not influence coagulation activation, lung inflammation or survival in lethal influenza A.

  5. It suggested that there could be a combination of GLA (zeige GLA Antikörper) deficiency and FVL or other thrombosis-related gene defect in patients with genetic severe early-onset thrombosis.

  6. Data suggest that tissue factor (zeige F3 Antikörper) and factor V induction by LPS (zeige TLR4 Antikörper) may in part accelerate mesangioproliferative glomerulonephritis through activation of factor X and downstream proinflammatory and procoagulant mechanisms.

  7. The source of the FVL leading to accelerated thrombosis appears to be circulating, non-platelet-derived plasma FVL.

  8. FVL has the ability to improve the hemophilia A or B phenotype, but this effect is principally evident at the microcirculation level following a particular vascular injury.

  9. observations demonstrate a synergistic interaction between alpha-galactosidase A (zeige GLA Antikörper) deficiency and Factor V Leiden toward tissue fibrin deposition; concomitant mutations in these genes may increase the penetrance of vascular thrombotic events in humans

  10. Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers.

Human Coagulation Factor V (F5) Interaktionspartner

  1. Factor Va reduced by 100-fold the apparent Kd of myosin for factor Xa (zeige F10 Antikörper) (Kd approximately 0.48 nM), primarily by reducing koff, indicating formation of a stable ternary complex of myosin:Xa:Va.

  2. there is a synergistic effect of the FVL and rs4524 single nucleotide polymorphisms and active cancer on the risk of VTE.

  3. Our finding that the C2-domain of FVIII (zeige F8 Antikörper) can be replaced by that of FV without compromising FVIII (zeige F8 Antikörper) activity may have translational implications.

  4. These results demonstrate a new anticoagulant (cofactor) function of FV that targets the early phase of coagulation before prothrombinase (zeige F10 Antikörper) assembly

  5. There was an increased odds of stillbirth for maternal homozygous factor V Leiden mutation.

  6. Factor V Leiden was not associated with recurrent miscarriage during the first trimester of pregnancy in Brazilian women.

  7. The prevalence of factor V G1691A, prothrombin (zeige F2 Antikörper) G20210A and MTHFR (zeige MTHFR Antikörper) C677T single nucleotide polymorphism among Syrians is 11.5%, 2.5% and 84.5%, respectively.

  8. Desmopressin acetate has no effect on FV plasma concentration in patients with combined deficiency of factors V and VIII (zeige COX8A Antikörper).

  9. F5 rs6025 and F11 (zeige F11 Antikörper) rs2289252 contributed to the risk of recurrent venous thromboembolism and the combination is of potential clinical relevance for risk prediction

  10. Data does not support a role for factor V Leiden and G20210A prothrombin (zeige F2 Antikörper) gene mutations in the susceptibility to infective endocarditis.

Cow (Bovine) Coagulation Factor V (F5) Interaktionspartner

  1. Data suggest factor Xa (FXa (zeige F10 Antikörper)) and factor Va (FVa) compete to bind FXa (zeige F10 Antikörper) on both PS model membranes and microparticles from activated platelets; this competition between dimerization/prothrombinase (zeige FGL2 Antikörper) complex formation appears to regulate blood coagulation.

Coagulation Factor V (F5) Antigen-Profil

Protein Überblick

This gene encodes an essential cofactor of the blood coagulation cascade. This factor circulates in plasma, and is converted to the active form by the release of the activation peptide by thrombin during coagulation. This generates a heavy chain and a light chain which are held together by calcium ions. The activated protein is a cofactor that participates with activated coagulation factor X to activate prothrombin to thrombin. Defects in this gene result in either an autosomal recessive hemorrhagic diathesis or an autosomal dominant form of thrombophilia, which is known as activated protein C resistance.

Genbezeichner und Symbole assoziert mit F5

  • coagulation factor V (LOC100534566) Antikörper
  • coagulation factor V (F5) Antikörper
  • coagulation factor V (proaccelerin, labile factor) (F5) Antikörper
  • Ac2-120 Antikörper
  • AI173222 Antikörper
  • Cf-5 Antikörper
  • Cf5 Antikörper
  • FVL Antikörper
  • PCCF Antikörper
  • RPRGL1 Antikörper
  • THPH2 Antikörper

Bezeichner auf Proteinebene für F5

coagulation factor V , activated protein C cofactor , activated protein c cofactor , coagulation factor V jinjiang A2 domain , factor V Leiden , proaccelerin, labile factor

GENE ID SPEZIES
100534566 Oreochromis niloticus
14067 Mus musculus
2153 Homo sapiens
304929 Rattus norvegicus
280687 Bos taurus
100715882 Cavia porcellus
397217 Sus scrofa
100685858 Canis lupus familiaris
101123649 Ovis aries
Ausgewählte Anbieter für anti-Coagulation Factor V (F5) Antikörper
Haben Sie etwas anderes gesucht?